NewsEngineered nanomaterial captures off-target cancer drug to
prevent tissue damage

5th January 2022by admin0
https://nfusion-tech.com/wp-content/uploads/2022/01/engineered-nanomaterial-captures-off-target-cancer-drug-toprevent-tissue-damage_61d6b8fdaf15e.jpeg

Standard chemotherapies may efficiently kill cancer
cells, but they also pose significant risks to healthy cells,
resulting in secondary illness and a diminished quality of life for
patients. To prevent the previously unavoidable damage,
researchers, led by Penn State, have developed a new class of
nanomaterials engineered to capture chemotherapy drugs before they
interact with healthy tissue.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2022 New Fusion All Rights Reserved

      Designed by FallingBrick